Gag CA-SP1 immature lattice bound with Lenacapavir and Bevirimat from enveloped virus like particles
Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
homo-18-mer
Ligands
18 x
QNG:
N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide(Non-covalent)
3 interactions with chain C,
4 interactions with chain B
Salt bridges:
C:K.150,
C:K.219,
C:K.219,
B:K.150,
B:K.150,
B:K.219,
B:K.219
IHP.10:
4
residues within 4Å:
Chain E:
K.150,
K.219
Chain F:
K.150,
K.219
7 PLIP interactions:
3 interactions with chain F,
4 interactions with chain E
Salt bridges:
F:K.150,
F:K.219,
F:K.219,
E:K.150,
E:K.150,
E:K.219,
E:K.219
IHP.15:
4
residues within 4Å:
Chain H:
K.150,
K.219
Chain I:
K.150,
K.219
7 PLIP interactions:
3 interactions with chain I,
4 interactions with chain H
Salt bridges:
I:K.150,
I:K.219,
I:K.219,
H:K.150,
H:K.150,
H:K.219,
H:K.219
IHP.20:
4
residues within 4Å:
Chain K:
K.150,
K.219
Chain L:
K.150,
K.219
7 PLIP interactions:
3 interactions with chain L,
4 interactions with chain K
Salt bridges:
L:K.150,
L:K.219,
L:K.219,
K:K.150,
K:K.150,
K:K.219,
K:K.219
IHP.22:
12
residues within 4Å:
Chain A:
K.150,
K.219
Chain D:
K.150,
K.219
Chain G:
K.150,
K.219
Chain J:
K.150,
K.219
Chain M:
K.150,
K.219
Chain P:
K.150,
K.219
13 PLIP interactions:
3 interactions with chain A,
2 interactions with chain J,
3 interactions with chain G,
1 interactions with chain P,
3 interactions with chain M,
1 interactions with chain D
Wu, C. et al., Structural insights into inhibitor mechanisms on immature HIV-1 Gag lattice revealed by high-resolution in situ single-particle cryo-EM. Biorxiv (2024)